Fondazione Policlinico Universitario A.Gemellli IRCCS
Gynecologic Oncology
Domenica Lorusso, MD, PhD, is associate professor of obstetrics and gynecology at Fondazione Policlinico Universitario A Gemelli in Rome. She obtained her medical degree from the Catholic University of Rome in 1995 and her PhD in obstetrics and gynaecology from the University of Parma in 2003. Dr Lorusso has been involved in gynaecological oncology research for more than 25 years and has conducted or participated in approximately 200 phase I-IV clinical trials in gynaecological malignancies. At present she is Principal Investigators of more than 60 studies. Dr Lorusso is responsible of the Clinical Trials Committee of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynaecological Malignancies) Group, which includes more than 150 Italian centres involved in gynaecological oncology research. She is member of Board of Directors of Gynaecological Cancer Intergroup including 23 international research groups involved into the promotion and conduction of high quality clinical trials to improve outcomes for women with gynaecological cancers. Dr Lorusso is also active member of ENGOT (European Network of Gynaecological Oncological Trial groups) an international organisation which coordinates and promotes clinical trials within Europe for patients with gynaecological cancers where she chiars the Gynecological cancer Accademy. She has also co-authored about 300 international oncology publications. She is author of national and international guidelines on treatment of ovarian, cervical and endometrial cancer. Dr Lorusso’s key goals are to promote clinical research, international trial collaborations and educations.

Moderator of 2 Sessions

Poster Rounds & Sponsor Conversation Break

Session Type
Poster Rounds & Sponsor Conversation Break
Date
09/30/2022
Session Time
11:55 AM - 12:25 PM
Room
Sponsor Conversation Area
Session Icon
Onsite Only
Session Description
Poster Rounds Groups C1, C2 & C3. For the full schedule, please click on the Poster Rounds green button on top of the interactive program or visit the IGCS 2022 Mobile App.
Session Type
Master Session
Date
10/01/2022
Session Time
10:05 AM - 12:05 PM
Room
Hall 501
Session Icon
Live
Session Description
The session will focus on the state of the art of HPV vaccination in cervical cancer prevention programs.Attendees will be informed about the controversies about the surgical treatment in cervical cancer.Resource-based radiotherapy treatment standard will be provided.Latest news in immunotherapy and new agents in the treatment of cervical cancer will be discussed.A deeper focus on molecular and pathologic characteristics of cervical cancer will be discussed.

Presenter of 7 Presentations

Panel Case Discussion

Session Type
Industry Symposia
Date
09/29/2022
Session Time
11:55 AM - 01:25 PM
Room
Hall 406
Lecture Time
12:10 PM - 12:55 PM

The role of immunotherapy in cervical cancer

Session Type
Master Session
Date
10/01/2022
Session Time
10:05 AM - 12:05 PM
Room
Hall 501
Session Icon
Live
Lecture Time
11:20 AM - 11:35 AM
Onsite or Pre-Recorded
Onsite

• PANEL 2 - DISCUSSION

ADC Technology and Biomarkers Driving Clinical Development

Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 406
Lecture Time
12:30 PM - 12:45 PM

Polling and Q&A Session

– DEBATE: Pro for systemic treatment

Session Type
Master Session
Date
09/29/2022
Session Time
01:55 PM - 04:10 PM
Room
Hall 501
Session Icon
Live
Lecture Time
03:12 PM - 03:21 PM
Onsite or Pre-Recorded
Onsite

Distillation & Q&A

Session Type
Plenary Session
Date
09/29/2022
Session Time
08:00 AM - 10:30 AM
Room
Hall 501
Session Icon
Live
Lecture Time
08:18 AM - 08:25 AM
Onsite or Pre-Recorded
Onsite